None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: ? Age 18-35 years ? > 40 completed weeks of gestation ? Singleton fetus ? Cephalic presentation ? Absence of uterine contractions ? Unfavorable cervix (Bishop<6) ? Intact membranes ? Reactive NST
Exclusion criteria
Exclusion criteria: . Fetal malpresentation ? Antepartum hemorrhage ? Previous uterine incision ? Ruptured membranes ? Contraindication to receive IMN or Prostaglandins (allergy, bronchial asthma, hypotension, palpitation) ? Pregnancy with high risk factors (Preeclampsia, Oligohydramnios, IUGR, medical complications such as diabetes mellitus, heart disease and hypertension.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Bishop score: Pre & Post treatment with the drug 2. Time elapsed from hospital admission (for patient induction / admission in labor) to delivery either vaginally or cesarean section. 3. Adverse maternal outcome: Uterine hyperstimulation, tachysystole, tachycardia, hypotension, headache, palpitations, fever & shivering. 4. Adverse fetal outcome: meconium stained liquor, Apgar at 1 & 5 minutes, neonatal admission. Timepoint: nil | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Unscheduled admissions for reasons other than labor commencing. 2. Requirement of additional inpatient cervical ripening agent. 3. Subsequent need for oxytocin. 4. Operative delivery rates (Cesarean section done for obstetric indications including failed induction, arrest of dilation, arrest of descent, and persistent non reassuring fetal heart rate pattern after resuscitation). 5. Complications: Postpartum hemorrhage. Timepoint: nil | — |
Countries
India
Contacts
Senior Specialist